Financials
- Market Capitalization 90.64 M
- Employee 10
- Founded 2012
- CEO N/A
- Website www.atarabio.com
- Headquarter Delaware, United States
- FIGI BBG005Q3MQY4
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
7.04
Rapporto prezzo/fatturato
1.9
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3980 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 1.51 USD | -1.95% | -1.95% | -4.43% | -74.23% | 91.09 M USD | ||
| 3982 | ICCC ImmuCell Corporation - Common Stock | 10.00 USD | -0.20% | -0.89% | -10.71% | +58.98% | 90.82 M USD | ||
| 3997 | ACRV Acrivon Therapeutics, Inc. - Common Stock | 2.07 USD | -3.72% | -5.91% | +38.00% | +55.64% | 88.71 M USD | ||
| 3998 | RLYB Rallybio Corporation - Common Stock | 16.70 USD | -0.36% | +0.60% | +3.09% | +2992.59% | 88.69 M USD |